ACHE and Parkinson disease: The pharmacological fields most explored in the past decade have been neurodegenerative disorders, especially Alzheimer’s or Parkinson’s diseases, due to interaction with AChE and MAO-B, respectively, but also including effects on inflammation or on the cardiovascular system, and in the field of chemotherapeutic agents, with special attention to different types of cancer.